ID   KR-12
AC   CVCL_3732
SY   KR12
DR   CLO; CLO_0007119
DR   ATCC; CRL-8658
DR   BioSample; SAMN03471206
DR   TKG; TKG 0216
DR   Wikidata; Q54900448
RX   Patent=US4693975;
RX   PubMed=3365703;
RX   PubMed=6092464;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8658.
CC   Selected for resistance to: ChEBI; CHEBI_472805; Ouabain.
CC   Selected for resistance to: ChEBI; CHEBI_9555; Tioguanine (6-thioguanine; 6-TG).
CC   Discontinued: ATCC; CRL-8658; true.
ST   Source(s): ATCC=CRL-8658
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11,12
ST   D16S539: 9,11
ST   D5S818: 10,11,13
ST   D7S820: 9,10
ST   TH01: 8,9,9.3
ST   TPOX: 8
ST   vWA: 16,18,19
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_0014 ! RPMI-8226
HI   CVCL_H617 ! GM1500-6TG-OUB
CA   Hybrid cell line
DT   Created: 04-04-12; Last updated: 19-12-24; Version: 17
//
RX   Patent=US4693975;
RA   Kozbor D., Croce C.M.;
RT   "Human hybridoma fusion partner for production of human monoclonal
RT   antibodies.";
RL   Patent number US4693975, 15-Sep-1987.
//
RX   PubMed=3365703;
RA   Kjeldsen T.B., Rasmussen B.B., Rose C., Zeuthen J.;
RT   "Human-human hybridomas and human monoclonal antibodies obtained by
RT   fusion of lymph node lymphocytes from breast cancer patients.";
RL   Cancer Res. 48:3208-3214(1988).
//
RX   PubMed=6092464; DOI=10.4049/jimmunol.133.6.3001;
RA   Kozbor D., Tripputi P., Roder J.C., Croce C.M.;
RT   "A human hybrid myeloma for production of human monoclonal
RT   antibodies.";
RL   J. Immunol. 133:3001-3005(1984).
//